scholarly journals FLUORESCEIN-CONJUGATED BOVINE ALBUMIN

1953 ◽  
Vol 36 (4) ◽  
pp. 489-506 ◽  
Author(s):  
Alfred A. Schiller ◽  
Richard W. Schayer ◽  
E. L. Hess

Fluorescein-bovine albumin conjugates have been prepared and found not to differ appreciably in size, shape, and homogeneity from the precursor, bovine serum albumin. Fluorescein has also been conjugated to rat plasma proteins. Their disappearance rates from the circulation of rats correspond with those obtained from the use of isotope labeling. Their sites of localization in rat tissues were shown to be in the cytoplasm but not in the nuclei of Kupffer cells, fixed macrophages, granulocytes, and proximal renal tubules. Adsorption to endothelium was a characteristic finding. Extracellular localizations were predominantly in the lumina of blood vessels and proximal renal tubules (but never in the lumina of collecting tubules), and the interstitial fluid of skeletal and cardiac muscle (but not that of glandular organs such as the adrenals, liver, and spleen). BAC absorption from the skin of rabbits requires days whereas sodium fluorescein absorption is measured in hours, attesting to the persistence of the colloidal state of BAC in vivo. Fluorescein conjugates have been used to visualize the transcapillary passage of circulating proteins in the mesenteric circulation of frogs and rats by direct microscopic observation and found to diffuse slowly in the manner predicted for plasma proteins. The normal cutaneous vessels of the rat are impermeable in the gross to the labeled proteins; second degree burn promptly increases the permeability of these vessels rendering the presence of the label detectable in the gross in the skin. The process of labeling does not render guinea pig albumin antigenic, although slight antigenicity results from labeling whole plasma protein. It is believed that sufficient biological evidence is presented to support the conclusion that fluorescein-conjugated plasma proteins, particularly albumin, behave in vivo like their native precursors.

1962 ◽  
Vol 40 (2) ◽  
pp. 153-157 ◽  
Author(s):  
Anita Berecz ◽  
C. Godin

When 7-azatryptophan and 5-methyltryptophan are fed to protein-depleted rats, the animals lose weight more rapidly than control rats. Protein-depleted rats fed a diet containing tryptophan gain weight. 7-Azatryptophan is incorporated in vivo into rat plasma proteins, whereas 5-methyltryptophan is not incorporated.


1994 ◽  
Vol 141 (3) ◽  
pp. 459-466 ◽  
Author(s):  
M M Ho ◽  
S Barker ◽  
G P Vinson

Abstract Previous studies using a mouse monoclonal antibody (IZAb) have identified inner zone-specific antigens (IZAg 1 and 2) in the rat adrenal cortex. The expression of IZAgl is enhanced by dibutyryl-cyclic AMP or ACTH in vitro and by in vivo ACTH treatment. These studies also suggest that IZAg may be involved in steroidogenesis in rat adrenals. Using sensitive detection methods, the distribution of IZAg in adrenals from other species and in other rat tissues was studied. Pig and rabbit adrenals expressed an IZAb-immunoreactive protein with molecular mass identical with that of IZAg1, but no immunoreactivity was detected in bovine, guinea-pig or mouse adrenals. In the rabbit adrenal, as in the rat, IZAb bound only to zonae fasciculata/reticularis cells. However, the whole adrenal cortex in the pig immunoreacted with IZAb. Although immunofluorescence was observed in human adrenal sections, predominantly in the zona reticularis, no significant immunoreactive protein band was detected by immunoblot analysis. Apart from the zonae fasciculata/reticularis in the adrenal gland, an IZAb-immunoreactive protein with a molecular mass of 26 000 Da, corresponding to IZAg1, was also found in rat hepatocytes, renal tubules, ovary (corpus luteum, interstitial cells, theca interna of mature follicles) and Leydig cells. The observations suggest that IZAg may be involved in the processes of biosynthesis, metabolism and/or excretion of steroid hormones. Journal of Endocrinology (1994) 141, 459–466


1962 ◽  
Vol 40 (1) ◽  
pp. 153-157 ◽  
Author(s):  
Anita Berecz ◽  
C. Godin

When 7-azatryptophan and 5-methyltryptophan are fed to protein-depleted rats, the animals lose weight more rapidly than control rats. Protein-depleted rats fed a diet containing tryptophan gain weight. 7-Azatryptophan is incorporated in vivo into rat plasma proteins, whereas 5-methyltryptophan is not incorporated.


1961 ◽  
Vol 37 (1) ◽  
pp. 148-152 ◽  
Author(s):  
Leo E. Reichert ◽  
Maurice V. L'Heureux

ABSTRACT Comparative studies are reported on the effect of dialysis and peroxide oxidation upon the calcium mobilizing activity of a potent parathyroid gland preparation, Injection Parathyroid, U. S. P. (Lilly), when in aqueous solution and when incubated with freshly collected rat plasma prior to treatment. It was found that although dialysis and oxidation markedly decreased the potency of the parathyroid gland extract employed, prior incubation with rat plasma prevented this effect from occurring. It is suggested that a binding of the active principle of the extract to plasma proteins could account for the phenomena observed. The suggestion that oxidative inactivation of parathyroid hormone is of significance, in vivo, would not seem to be in accord with the observations recorded here.


1969 ◽  
Vol 22 (03) ◽  
pp. 577-583 ◽  
Author(s):  
M.M.P Paulssen ◽  
A.C.M.G.B Wouterlood ◽  
H.L.M.A Scheffers

SummaryFactor VIII can be isolated from plasma proteins, including fibrinogen by chromatography on agarose. The best results were obtained with Sepharose 6B. Large scale preparation is also possible when cryoprecipitate is separated by chromatography. In most fractions containing factor VIII a turbidity is observed which may be due to the presence of chylomicrons.The purified factor VIII was active in vivo as well as in vitro.


1996 ◽  
Vol 75 (01) ◽  
pp. 118-126 ◽  
Author(s):  
T Abrahamsson ◽  
V Nerme ◽  
M Strömqvist ◽  
B Åkerblom ◽  
A Legnehed ◽  
...  

SummaryThe aim of this study was to investigate the anti-thrombotic effects of an inhibitor of the plasminogen activator inhibitor-1 (PAI-1) in rats given endotoxin. In studies in vitro, PRAP-1, a Fab-fragment of a polyclonal antibody against human PAI-1, was shown to inhibit PAI-1 activity in rat plasma as well as to stimulate clot-lysis of the euglobulin fraction derived from rat plasma. Endotoxin administered to anaesthetised rats produced a marked increase in plasma PAI-1 activity. To study fibrin formation and lysis in vivo after intravenous (i. v.) injection of the coagulant enzyme batroxobin, 125I-fibrinogen was administered to the animals. The thrombi formed by batroxobin were rapidly lysed in control animals, while the rate of lysis was markedly attenuated in rats given endotoxin. PRAP-1 was administered i.v. (bolus + infusion) to rats given endotoxin and batroxobin and the PAI-1 inhibitor caused a dose-dependent decrease in the 125I-fibrin deposition in the lungs. An immunohistochemical technique was used to confirm this decrease in density of fibrin clots in the tissue. Furthermore, PRAP-1 decreased plasma PAI-1 activity in the rats and this reduction was correlated to the decrease in lung 125I-fibrin deposition at the corresponding time point. It is concluded that in this experimental model the PAI-1 antibody PRAP-1 may indeed inhibit thrombosis in animals exposed to endotoxin.


1994 ◽  
Vol 200 (1) ◽  
pp. 298-305 ◽  
Author(s):  
V.M. Fazio ◽  
S. Fazio ◽  
M. Rinaldi ◽  
M.V. Catani ◽  
S. Zotti ◽  
...  

1971 ◽  
Vol 66 (3) ◽  
pp. 417-430 ◽  
Author(s):  
R. D. Hertogh ◽  
E. Ekka ◽  
I. Vanderheyden
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document